ArticleEuropean journal of medical research2025
Association of C-reactive protein to albumin ratio with prevalence and mortality in metabolic syndrome: NHANES 1999-2010.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of C-reactive protein to albumin ratio with progression of CKD and all-cause mortality in diabetic CKD.Journal of endocrinological investigation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundMetabolic syndrome (MetS) is closely related to inflammation and oxidative stress. C-reactive protein to albumin ratio (CAR) is an inflammatory and nutritional marker, and this study aims to explore its relationship with the occurrence and prognosis of MetS.
methodsThe study utilized data derived from the National Health and Nutrition Examination Survey 1999-2010. Among the 11,669 adult participants, 4,290 (33%) were diagnosed with MetS. Multivariate logistic regression was employed to investigate the association between CAR and MetS. To assess the impact of CAR on all-cause and cardiovascular mortality among people with MetS, Kaplan-Meier survival curve, Cox proportional risk model, restricted cubic spline, and receiver operating characteristic (ROC) curve were used.
resultsThis study showed that the highest CAR quantile level was strongly association with the prevalence of MetS in the population (OR = 4.92 95% CI 4.19-5.77 P < 0.001). In people with MetS, elevated CAR increased the risk of all-cause death (HR = 1.51 95% CI 1.27-1.79 P < 0.001) and cardiovascular death (HR = 1.65 95% CI 1.29-2.09 P < 0.001). The ROC curve indicated the predictive value of CAR for all-cause death in people with MetS (AUC = 0.64).
conclusionOur findings demonstrate the predictive value of CAR for the prevalence and mortality due to MetS, and highlight the role of inflammation in the development and prognosis of MetS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.